National Accounts Leader - Payer Strategy & Access

IQVIA; Chicago (IL); On-site; USD 126,000 - 351,000; Full time

Job summary

IQVIA seeks a Director, National Accounts to lead the national accounts strategy for the company’s first commercial product launch. You will manage executive‑level relationships with PBMs, GPOs, and national payers across Commercial, Medicare, and Medicaid.

You will shape pricing, contracting, reimbursement, and access strategies to drive product adoption and patient access in a fast‑paced biotech environment.

Qualifications

• Bachelor's degree required.
• 10+ years of progressive experience in pharmaceutical, biotechnology, specialty pharmaceutical, or healthcare organizations.
• Minimum 5+ years of direct national account management experience with responsibility for Payer GPOs, PBMs, National Health Plans (to include government payers VA, DoD, and Medicaid).

Responsibilities

• Develop and implement a comprehensive national accounts strategy to support launch readiness and long‑term commercial success.
• Lead negotiations and management of rebate, formulary, and value‑based agreements with PBMs and health plans.
• Collaborate with Pricing, Market Access, Finance, Legal, and Compliance to develop contract strategies and evaluate financial implications.
• Support launch planning and provide account insights to forecast pricing strategy and patient access programs.
• Develop processes and analytics to support national account management in a growing organization.

Skills

Executive relationships

Payer contracting

Pricing strategy

Cross-functional leadership

Healthcare payer landscape

Negotiation

Education

Bachelor's degree

Job description

IQVIA seeks a Director, National Accounts to lead the national accounts strategy for the company’s first commercial product launch. You will manage executive‑level relationships with PBMs, GPOs, and national payers across Commercial, Medicare, and Medicaid.

You will shape pricing, contracting, reimbursement, and access strategies to drive product adoption and patient access in a fast‑paced biotech environment.